These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 27247496

  • 1. Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S, Kim JH, Oh SS, Lee MR, Jung JH, Chung HC, Cha SK, Eom M.
    J Korean Med Sci; 2016 Jun; 31(6):879-85. PubMed ID: 27247496
    [Abstract] [Full Text] [Related]

  • 2. Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma.
    Kim JH, Lkhagvadorj S, Lee MR, Hwang KH, Chung HC, Jung JH, Cha SK, Eom M.
    Biochem Biophys Res Commun; 2014 May 23; 448(1):76-82. PubMed ID: 24755083
    [Abstract] [Full Text] [Related]

  • 3. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
    Xia J, Wang H, Huang H, Sun L, Dong S, Huang N, Shi M, Bin J, Liao Y, Liao W.
    Cancer Lett; 2016 Oct 10; 381(1):31-40. PubMed ID: 27431311
    [Abstract] [Full Text] [Related]

  • 4. Orai1 and Stim1 Mediate the Majority of Store-Operated Calcium Entry in Multiple Myeloma and Have Strong Implications for Adverse Prognosis.
    Wang W, Ren Y, Wang L, Zhao W, Dong X, Pan J, Gao H, Tian Y.
    Cell Physiol Biochem; 2018 Oct 10; 48(6):2273-2285. PubMed ID: 30114708
    [Abstract] [Full Text] [Related]

  • 5. Functional consequences of enhanced expression of STIM1 and Orai1 in Huh-7 hepatocellular carcinoma tumor-initiating cells.
    Karacicek B, Erac Y, Tosun M.
    BMC Cancer; 2019 Jul 31; 19(1):751. PubMed ID: 31366337
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of Orai1 and STIM1 expression as well as store-operated Ca2+ entry in ovary carcinoma cells by placental growth factor.
    Abdelazeem KNM, Droppova B, Sukkar B, Al-Maghout T, Pelzl L, Zacharopoulou N, Ali Hassan NH, Abdel-Fattah KI, Stournaras C, Lang F.
    Biochem Biophys Res Commun; 2019 May 07; 512(3):467-472. PubMed ID: 30902388
    [Abstract] [Full Text] [Related]

  • 7. The STIM1-Orai1 pathway of store-operated Ca2+ entry controls the checkpoint in cell cycle G1/S transition.
    Chen YW, Chen YF, Chen YT, Chiu WT, Shen MR.
    Sci Rep; 2016 Feb 26; 6():22142. PubMed ID: 26917047
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Lithium Sensitive Orai1/ STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin.
    Sukkar B, Hauser S, Pelzl L, Hosseinzadeh Z, Sahu I, Al-Maghout T, Bhuyan AAM, Zacharopoulou N, Stournaras C, Schöls L, Lang F.
    Cell Physiol Biochem; 2018 Feb 26; 51(1):278-289. PubMed ID: 30453283
    [Abstract] [Full Text] [Related]

  • 9. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.
    Debant M, Burgos M, Hemon P, Buscaglia P, Fali T, Melayah S, Le Goux N, Vandier C, Potier-Cartereau M, Pers JO, Tempescul A, Berthou C, Bagacean C, Mignen O, Renaudineau Y.
    J Immunother Cancer; 2019 Apr 23; 7(1):111. PubMed ID: 31014395
    [Abstract] [Full Text] [Related]

  • 10. NFAT5-sensitive Orai1 expression and store-operated Ca2+ entry in megakaryocytes.
    Sahu I, Pelzl L, Sukkar B, Fakhri H, Al-Maghout T, Cao H, Hauser S, Gutti R, Gawaz M, Lang F.
    FASEB J; 2017 Aug 23; 31(8):3439-3448. PubMed ID: 28446591
    [Abstract] [Full Text] [Related]

  • 11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M.
    Dan Med J; 2017 Oct 23; 64(10):. PubMed ID: 28975890
    [Abstract] [Full Text] [Related]

  • 12. High Expression of Orai1 Enhances Cell Proliferation and is Associated with Poor Prognosis in Human Colorectal Cancer.
    Gui L, Wang Z, Han J, Ma H, Li Z.
    Clin Lab; 2016 Sep 01; 62(9):1689-1698. PubMed ID: 28164587
    [Abstract] [Full Text] [Related]

  • 13. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR, Sha JJ, Liu DM, Chen YH, Yang GL, Zhang J, Chen YY, Bo JJ, Huang YR.
    Eur J Surg Oncol; 2013 Jan 01; 39(1):100-6. PubMed ID: 23102595
    [Abstract] [Full Text] [Related]

  • 14. Dominant role of Orai1 with STIM1 on the cytosolic entry and cytotoxicity of lead ions.
    Chiu TY, Teng HC, Huang PC, Kao FJ, Yang DM.
    Toxicol Sci; 2009 Aug 01; 110(2):353-62. PubMed ID: 19429662
    [Abstract] [Full Text] [Related]

  • 15. Lithium Sensitive ORAI1 Expression, Store Operated Ca2+ Entry and Suicidal Death of Neurons in Chorea-Acanthocytosis.
    Pelzl L, Hauser S, Elsir B, Sukkar B, Sahu I, Singh Y, Höflinger P, Bissinger R, Jemaà M, Stournaras C, Schöls L, Lang F.
    Sci Rep; 2017 Jul 25; 7(1):6457. PubMed ID: 28743945
    [Abstract] [Full Text] [Related]

  • 16. Mitochondrial Ca2+ uptake and not mitochondrial motility is required for STIM1-Orai1-dependent store-operated Ca2+ entry.
    Naghdi S, Waldeck-Weiermair M, Fertschai I, Poteser M, Graier WF, Malli R.
    J Cell Sci; 2010 Aug 01; 123(Pt 15):2553-64. PubMed ID: 20587595
    [Abstract] [Full Text] [Related]

  • 17. Combined immunodeficiency due to a homozygous mutation in ORAI1 that deletes the C-terminus that interacts with STIM 1.
    Badran YR, Massaad MJ, Bainter W, Cangemi B, Naseem SU, Javad H, Al-Tamemi S, Geha RS, Chou J.
    Clin Immunol; 2016 May 01; 166-167():100-2. PubMed ID: 27063589
    [Abstract] [Full Text] [Related]

  • 18. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
    Böhm J, Bulla M, Urquhart JE, Malfatti E, Williams SG, O'Sullivan J, Szlauer A, Koch C, Baranello G, Mora M, Ripolone M, Violano R, Moggio M, Kingston H, Dawson T, DeGoede CG, Nixon J, Boland A, Deleuze JF, Romero N, Newman WG, Demaurex N, Laporte J.
    Hum Mutat; 2017 Apr 01; 38(4):426-438. PubMed ID: 28058752
    [Abstract] [Full Text] [Related]

  • 19. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P, Ye L, Yang Y, Jiang WG.
    Anticancer Res; 2014 Nov 01; 34(11):6515-20. PubMed ID: 25368253
    [Abstract] [Full Text] [Related]

  • 20. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP, McKenney JK, Khor LY, Reynolds JP, Magi-Galluzzi C, Przybycin CG.
    Am J Surg Pathol; 2016 Feb 01; 40(2):141-54. PubMed ID: 26752401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.